Hyung-Don Kim, In-Ho Kim, Jae-Joon Kim, Tae-Hwan Kim, Jaewon Hyung, In-Seob Lee, Han Hong Lee, Young Soo Park, Jong Seok Lee, Min-Hee Ryu. "Multicenter phase Ib/II study of neoadjuvant zolbetuximab plus docetaxel, oxaliplatin, and S-1 (DOS) followed by adjuvant zolbetuximab/S-1 in patients with CLDN18.2-positive resectable gastric or gastroesophageal junction adenocarcinoma (NEOCLAUD).." Journal of Clinical Oncology, 2026. doi:10.1200/jco.2026.44.16_suppl.tps4250